The new Biden administration has announced a regulatory freeze to pause action on recent Trump administration regulations in order to consider withdrawing or revising them.
White House chief of staff Ron Klain sent a regulatory freeze memo to the heads of executive departments and agencies on 20 January requesting that they “consider” suspending action on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?